CORE--TUMOR PROCUREMENT

核心--肿瘤采购

• 批准号: 6269743
• 负责人: WILLIAM D HENNER
• 金额: $ 13.77万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-06-22 至 1999-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6269743
• 关键词: biomedical facility; histopathology; human tissue; neoplasm /cancer

The purpose of the Tumor Procurement Core Facility is to coordinate collection and use of primary human cancer specimens from patients who undergo surgery or autopsy at the University of Oregon and VAMC. These tissues will support both basic and translational research studies of Cancer Center members. In addition to obtaining samples of tumor and adjacent normal tissue, an IRB approved consent exists to allow the drawing of a sample of blood for preparation of DNA. This core also prepares slides for histologic confirmation of the presence of tumor in the specimen. Collection of demographic, pathologic and clinical data is performed to facilitate correlative studies and this information is entered into a computerized data base. Centralized collection of tumor samples minimizes the biohazards involved in handling human tissues and allows coding of samples to insure anonymity of patients. Since the previous grant submission a charge back system has been established.

肿瘤采购核心设施​​的目的是协调 从患者身上采集和使用原发性人类癌症标本 在俄勒冈大学接受手术或尸检的人 VAMC。 这些组织将支持基础和转化 癌症中心成员的研究。 除了获得 肿瘤和邻近正常组织样本，IRB 批准同意书 存在允许抽取血液样本以制备 脱氧核糖核酸。 该核心还准备载玻片以进行组织学确认 标本中存在肿瘤。人口统计的收集， 进行病理和临床数据以促进相关性 研究并将此信息输入计算机化数据库。 集中收集肿瘤样本可最大程度地减少生物危害 参与处理人体组织并允许对样本进行编码 确保患者的匿名性。自上次拨款提交以来 已建立退款制度。